Karumanchi SA - Search Results

1

Circulating angiogenic factors and the risk of preeclampsia.

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Levine RJ, et al. Among authors: karumanchi sa. N Engl J Med. 2004 Feb 12;350(7):672-83. doi: 10.1056/NEJMoa031884. Epub 2004 Feb 5. N Engl J Med. 2004. PMID: 14764923 Free article.

2

Renal cancer: molecular mechanisms and newer therapeutic options.

Karumanchi SA, Merchan J, Sukhatme VP. Karumanchi SA, et al. Curr Opin Nephrol Hypertens. 2002 Jan;11(1):37-42. doi: 10.1097/00041552-200201000-00006. Curr Opin Nephrol Hypertens. 2002. PMID: 11753085 Review.

3

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Maynard SE, et al. Among authors: karumanchi sa. J Clin Invest. 2003 Mar;111(5):649-58. doi: 10.1172/JCI17189. J Clin Invest. 2003. PMID: 12618519 Free PMC article.

4

First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA. Thadhani R, et al. Among authors: karumanchi sa. J Clin Endocrinol Metab. 2004 Feb;89(2):770-5. doi: 10.1210/jc.2003-031244. J Clin Endocrinol Metab. 2004. PMID: 14764795

5

Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.

Thadhani R, Ecker JL, Mutter WP, Wolf M, Smirnakis KV, Sukhatme VP, Levine RJ, Karumanchi SA. Thadhani R, et al. Among authors: karumanchi sa. Hypertension. 2004 May;43(5):988-92. doi: 10.1161/01.HYP.0000124460.67539.1d. Epub 2004 Mar 15. Hypertension. 2004. PMID: 15023932

6

Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights.

Bdolah Y, Sukhatme VP, Karumanchi SA. Bdolah Y, et al. Among authors: karumanchi sa. Semin Nephrol. 2004 Nov;24(6):548-56. doi: 10.1016/s0270-9295(04)00125-1. Semin Nephrol. 2004. PMID: 15529289 Review.

7

Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.

Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, Rajakumar A, Daftary A, Shakir AS, Seely EW, Roberts JM, Sukhatme VP, Karumanchi SA, Thadhani R. Wolf M, et al. Among authors: karumanchi sa. J Clin Endocrinol Metab. 2004 Dec;89(12):6239-43. doi: 10.1210/jc.2004-0548. J Clin Endocrinol Metab. 2004. PMID: 15579783

8

Urinary placental growth factor and risk of preeclampsia.

Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Levine RJ, et al. Among authors: karumanchi sa. JAMA. 2005 Jan 5;293(1):77-85. doi: 10.1001/jama.293.1.77. JAMA. 2005. PMID: 15632339

9

Uric acid and preeclampsia.

Lam C, Lim KH, Kang DH, Karumanchi SA. Lam C, et al. Among authors: karumanchi sa. Semin Nephrol. 2005 Jan;25(1):56-60. doi: 10.1016/j.semnephrol.2004.09.009. Semin Nephrol. 2005. PMID: 15660336

10

Is loss of podocyte foot processes necessary for the induction of proteinuria?

Karumanchi SA, Epstein FH, Stillman IE. Karumanchi SA, et al. Am J Kidney Dis. 2005 Feb;45(2):436. doi: 10.1053/j.ajkd.2004.11.022. Am J Kidney Dis. 2005. PMID: 15685527 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page